Aims: Permanent His bundle (HB) pacing is usually accompanied by simultaneous capture of the adjacent right ventricular (RV) myocardium -this is described as a non-selective (ns)-HB pacing. Our aim was to identify ECG criteria for loss of HB capture during ns-HB pacing.
Introduction
In contrast to the legacy ventricular pacing methods, His bundle (HB) pacing results in physiological activation of the ventricles via the specialized conduction system of the heart. In recent years several groups have reported encouraging outcomes of permanent HB pacing generating rapidly growing interest in this form of bradyarrhythmia and heart failure therapy. [1] [2] [3] [4] [5] [6] [7] [8] [9] Permanent HB pacing is usually accompanied by simultaneous engagement of the right ventricular (RV) working myocardium near the HB -this is described as a non-selective HB (ns-HB) pacing. 10 This new form of ventricular pacing deserves careful electrocardiograpic characterization, especially since it is present in the majority of patients who currently receive HB pacing devices. During HB pacing, high capture thresholds and significant threshold rise are observed in approximately 10% of patients. 10 Therefore, loss of HB capture during follow-up might be relatively common and masked by the still present RVonly myocardial pacing.
Although some ECG criteria for diagnosis of ns-HB pacing were arbitrary proposed, 11 their diagnostic value was never validated and it is currently not known if there are any ECG features/criteria that can allow conclusive diagnosis of loss of HB capture in patients with ns-HB pacing.
The aim of this study was to characterize the morphology of the QRS complex during ns-HB pacing in order to identify diagnostic features for either ns-HB capture or RV-only capture in patients implanted with HB pacing devices.
Methods

Study design
Consecutive patients in a tertiary cardiology center, implanted with a permanent His bundle pacing device between 2014-2019, were recruited. In all these patients permanent HB pacing was performed using a Medtronic (USA, Minneapolis) model 3830 lumenless, 4.1
French, active helix pacing lead that was screwed in to the His bundle area using standard methods for permanent HB pacing. 10, 12 Surface 12-lead ECGs during ns-HB pacing and during loss of ns-HB capture (i.e. with RV-only capture) were recorded. We included only patients in whom QRS morphologies during ns-HB capture and RV-only capture were confirmed with differential pacing output or programmed HB pacing; these two methods served as a gold standard diagnosis.
During the exploratory phase of the study, screening of QRS features (Figure 1) potentially diagnostic for His bundle capture/loss of His bundle capture was conducted using a randomly selected small population (15%) of all obtained ECGs. The following ECG features were chosen for the initial analysis: 1. global QRS duration, 2. R-wave peak time in lead V6 (RWPT) and 3. mid-QRS notch or slur/plateau in leads I, II/III/aVF, aVL, V1 and V4-V6.
Features identified as most promising for the diagnosis of ns-HB pacing and/or RVonly myocardial capture in the exploratory phase of the study were chosen for construction of an algorithm. Moreover, criteria for definitive confirmation of HB capture were proposed. For the validation phase, we used a separate set of electrocardiograms from different patients.
During the final phase of the study, a post-hoc analysis of false positives was made.
Diagnostic mistakes where ns-HB pacing was diagnosed as RV-only pacing were analyzed with the aim to elucidate the reasons behind the misleading paced QRS morphologies.
ECG assessment
The paced QRS duration and lead V6 RWPT time were assessed in all studied ECGs using semiautomatic measurements (manually positioned digital calipers, paper speed of 100 ms/s, high signal augmentation presented as percentages. Between group differences were assessed using the Fisher exact test for 2 x 2 table or Student's t-test, as appropriate. The performance of binary decision rules was described using diagnostic accuracy (ACC), sensitivity (SN) and specificity (SP). The performance of the QRS duration and V6 RWPT in discriminating between ns-HB and RV pacing was assessed using the receiver operating characteristic curve (ROC). Statistical analyses were performed in "R". P-values < 0.05 were considered statistically significant.
Results
Exploratory and validation stages
A total of 353 ECGs obtained from 226 patients were analyzed (127 patients provided both ns-HB ECG and RV-only ECG). Clinical characteristics of this cohort are presented in Table 1 . Diagnostic properties of the ECG features that were assessed in the exploratory phase of the study (51 ECGs from 27 patients) are presented in Table 2 . Briefly, QRS notch/slur/plateau in leads I and V4-V6 as well as lead V6 RWPT > 110-120 ms were found to be highly diagnostic for loss of HB capture while lead V6 RWPT ≤ 100 ms and no QRS notches/slurs in leads I, V1, V4-V6 were found specific for ns-HB capture. On the other hand, leads II, III, aVF and aVL were found to be not useful for the diagnosis of loss of HB capture as notch/slur was observed in these leads during both ns-HB and RV-only pacing. On the basis of these findings, a simple "HB ECG algorithm" for loss of HB capture and also criteria for a 100% definitive diagnosis of ns-HB pacing (SP of 100%) were proposed. Loss of HB capture is to be diagnosed when either there is a notch/slur/plateau in any of the leads: I, V4- patients with correct diagnosis of ns-HB capture, 55.5% vs. 14.1%, respectively (p=0.000).
The percentage of patients with RBBB in these two subgroups, 25.0% vs. 23.1%, respectively, did not differ.
These results prompted sub-analysis of the algorithm performance in patients with normal HV interval (≤ 55ms) and normal QRS duration (<110 ms). There were 103 patients with such characteristics that have provided 143 ECG (52 RV-only and 92 ns-HB). The sensitivity, specificity and accuracy of 96.1%, 96.7% and 96.5 %, respectively.
Discussion
The major finding of the current study is that despite significant overlap in QRS morphology between paced ns-HB QRS and paced RV-only QRS, there are also important differences. We have found that QRS notching/slurring in the left ventricular leads and Rwave peak time in lead V6 enable accurate ECG algorithm-based diagnosis for loss of HB capture in patients with permanent HB pacing devices.
QRS notching and slurring
The development of notches/slurs in left ventricular leads -that appear immediately with the loss of HB capture -provide a criterion that is most straightforward to assess. These RWPT criterion parallels the recognized LBBB criterion of time to intrinsicoid deflection > 60 ms in lead V6. 4 The important difference is that in case of ns-HB pacing, the His-ventricle (HV) interval always increases RWPT by 40-50 ms. This explains why in case of ns-HB pacing, the differentiating value for RWPT must be > 110 ms rather than > 60 ms. We believe that lead V6 RWPT is better suited for diagnosis of loss of HB capture than QRS duration:
firstly, it offers better separation between ns-HB and RV-only pacing than QRS duration evaluated by the distribution of QRS and lead V6 RWPT values between this two types of pacing, and by bigger area under the ROC curve ( Figures 3 and 4) ; secondly, it is better associated with the primary goal of HB pacing (physiological, fast and synchronous activation of the left ventricle). This is especially evident in patients with non-corrected RBBB, where QRS is usually prolonged due to the r' in lead V1 while RWPT in lead V6 is not influenced and remains < 100 ms (Supplementary Figure 1) . Thirdly, RWPT is more suitable for precise measurements with the naked eye, as R-wave peak offers a very distinct point while determination of the QRS end is prone to interobserver variability, leading to the well-known imprecision of manual QRS duration assessment.
Importantly, diagnostic mistakes of our algorithm, due to RWPT > 110 ms in patients with preserved ns-HB pacing were predominantly caused by prolonged baseline HV interval that was most likely not corrected by HB pacing (Figure 5 ). In such cases, with HV interval of 60-80 ms, the depolarization wavefront from RV-myocardial capture has enough time to cross the interventricular septum and limit the contribution of the depolarization wavefront from the His-Purkinje system. Patients identified by such QRS characteristics -pointing to not complete normalization of the left ventricular activation -might benefit from additional pacing options. It was showed that simultaneous left ventricular pacing can further shorten QRS duration in patients in whom HB pacing do not fully normalize QRS complexes
The QRS duration criterion based on an arbitrarily selected cut-off point of < 120-130 ms was proposed by others for diagnosis of ns-HB pacing. 6, 11 However, this criterion was (Figure 3) . This parallels the situation seen during differentiation between RV-only QRS and biventricular paced QRS during cardiac resynchronization therapy. 16 Nevertheless, QRS duration can also be used for differentiation between ns-HB pacing and RV-only myocardial capture. A diagnostically optimal differentiating cut-off point, on the basis of the ROC curve analysis and very precise global QRS duration measurements, seems to be around 150 ms; while values of < 120-130 ms are 100% specific for ns-HB capture but lack sensitivity for ns-HB capture diagnosis.
Criteria for firm diagnosis of ns-HB capture
The proposed algorithm categorizes paced ECGs in patients with presumed ns-HB pacing with adequate accuracy and compares well with ECG-based diagnostic methods from other clinical areas. 18 However, during the implant, criteria for achieving the procedural endpoint (i.e. HB capture) must be nearly 100% definitive to serve the purpose. For this reason, we sought to additionally develop criteria that would be 100% specific for diagnosis of ns-HB pacing. These were based on absence of any QRS features typical for RV-only myocardial pacing i.e. lack of any notches/slurs in leads I, V1, V4-V5 or rigorously defined delayed time to R-wave peak in lead V6 (not < 110 ms but ≤ 100 ms). The validation phase confirmed that such criteria are possible and are not only 100% specific but are also surprisingly sensitive (64% of ns-HB cases). We believe that these criteria might be used as a ancillary tool during the implant to confirm HB capture, especially in cases when HB and RV capture thresholds are equal and/or in facilities without capabilities of an electrophysiological laboratory where programmed His bundle pacing might be difficult to perform.
Limitations
The single-center recruitment of patients might have led to some bias that could reflect in ECG characteristics. The proposed criteria/algorithm might have different diagnostic value in populations with dissimilar clinical profile e.g. heart failure patients with LBBB.
Conclusions
Novel criteria and an ECG algorithm for diagnosis of HB capture/loss of HB capture in patients with permanent ns-HB pacing were proposed and validated. The ECG algorithm might be useful during follow-up and the criteria for definitive confirmation of ns-HB capture might offer a simple and reliable ancillary procedural endpoint during HB device implantation.
